Finance

Lists
Why is CSCI down 6,67%?
Dive Deeper
CSCI:TSE
COSCIENS Biopharma Inc
8,40 CA$
-6,67%
(-0,60) 1D
30 հոկ, 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CSCI...
Open
8,75 CA$
High
8,75 CA$
Low
8,40 CA$
Mkt. cap
8,92 մլն
Avg. vol.
585,00
Volume
300,00
P/E ratio
0,95
52-wk high
14,80 CA$
52-wk low
3,30 CA$
EPS
8,82 CA$
Beta
1,57
Shares outstanding
996,39 հզր
No. of employees
28
Open
8,75 CA$
High
8,75 CA$
Low
8,40 CA$
Mkt. cap
8,92 մլն
Avg. vol.
585,00
Volume
300,00
P/E ratio
0,95
52-wk high
14,80 CA$
52-wk low
3,30 CA$
EPS
8,82 CA$
Beta
1,57
Shares outstanding
996,39 հզր
No. of employees
28
News stories
From web sources and news partners
About COSCIENS Biopharma Inc
CEO-
Employees28
Founded1990
HeadquartersՏորոնտո, Օնտարիո, Կանադա
Sector-
Last report
11 օգս, 2026 թ.
Fiscal period
Q2 2026
- / -
Revenue / Est. (USD)
3,14 մլն / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,48 մլն
1,77 մլն
1,89 մլն
3,14 մլն
Cost of goods sold
938,00 հզր
1,16 մլն
1,10 մլն
1,41 մլն
Cost of revenue
938,00 հզր
1,16 մլն
1,10 մլն
1,41 մլն
Research and development expenses
527,00 հզր
599,00 հզր
176,00 հզր
132,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,10 մլն
2,40 մլն
1,35 մլն
1,18 մլն
Operating expense
2,63 մլն
3,00 մլն
1,52 մլն
1,32 մլն
Total operating expenses
3,57 մլն
4,15 մլն
2,62 մլն
2,72 մլն
Operating income
-2,08 մլն
-2,39 մլն
-730,00 հզր
422,00 հզր
Other non operating income
522,00 հզր
240,00 հզր
562,00 հզր
-680,00 հզր
EBT including unusual items
-1,82 մլն
-2,17 մլն
-183,00 հզր
-202,00 հզր
EBT excluding unusual items
-1,58 մլն
-2,17 մլն
-183,00 հզր
-202,00 հզր
Income tax expense
-
10,00 հզր
-
-
Effective tax rate
-
-0,46%
-
-
Other operating expenses
-
-
-
-
Net income
-1,82 մլն
-2,18 մլն
10,76 մլն
-202,00 հզր
Net profit margin
-122,66%
-123,61%
569,76%
-6,43%
Earnings per share
-
-
-
-
Interest and investment income
57,00 հզր
37,00 հզր
20,00 հզր
22,00 հզր
Interest expense
-43,00 հզր
-32,00 հզր
-46,00 հզր
-51,00 հզր
Net interest expenses
14,00 հզր
5,00 հզր
-26,00 հզր
-29,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,80 մլն
-2,36 մլն
-389,00 հզր
759,00 հզր
Gain or loss from assets sale
-
-
-11,28 մլն
29,00 հզր
Upcoming events
AI content may include mistakes. Learn more
Google Apps